The anti-inflammatory cytokine transforming growth factor-β (TGF-β) also promotes tumor progression in PDAC by inhibiting of immune activation, and deletion of the TGF-β receptor in CD8+ T cells enhanced infiltration and cytotoxicity of TILs in mouse models [21]. This evidence concerns the gene TGFB1 and neoplasm.